The RPTEC/TERT1 cell line models key renal cell responses to the environmental toxicants, benzo[a]pyrene and cadmium  by Simon, B.R. et al.
T
t
B
a
b
L
a
A
R
R
A
A
K
R
I
T
B
C
1
N
D
c
L
j
2
oToxicology Reports 1 (2014) 231–242
Contents lists available at ScienceDirect
Toxicology  Reports
journa l h om epa ge: www.elsev ier .com/ locate / toxrep
he  RPTEC/TERT1  cell  line  models  key  renal  cell  responses  to
he  environmental  toxicants,  benzo[a]pyrene  and  cadmium
.R.  Simona,b,  M.J.  Wilsonb,  J.K.  Wickliffeb,∗
Graduate Program in Biomedical Sciences, School of Medicine, Tulane University, New Orleans, LA 70112, United States of America
Department of Global Environmental Health Sciences, School of Public Health and Tropical Medicine, Tulane University, New Orleans,
A  70112, United States of America
 r  t  i c  l  e  i  n  f  o
rticle history:
eceived 4 April 2014
eceived  in revised form 14 May  2014
ccepted 21 May  2014
vailable  online 28 May  2014
eywords:
PTEC/TERT1
n vitro immortalized renal cell
ox21
enzo[a]pyrene
admium
a  b  s  t  r  a  c  t
We have  characterized  initial  canonical  responses  to  two  environmental  toxicants,  cad-
mium  (Cd)  and  benzo[a]pyrene  (B[a]P),  in a novel  in  vitro model  derived  from  renal  proximal
tubule  epithelial  cells  (RPTEC)  of  a  healthy  human  donor.  The  RPTEC/TERT1  cell  line has
been immortalized  using  the  human  telomerase  reverse  transcriptase  (hTERT)  subunit
only  and  does  not  exhibit  chromosomal  abnormalities.  RPTEC/TERT1  cells  were  exposed  to
single-compound  and  binary  mixtures  of Cd  and B[a]P,  known  or suspected  renal  toxicants
respectively.  Cells  exhibited  cytotoxicity  to concentrations  of  B[a]P  and  Cd  as low  as 1  nm
and  3  M,  respectively.  RPTEC/TERT1  cells  exhibited  compound-speciﬁc  gene  expression
responses  when  exposed  to 0.01–1  M B[a]P  and  0.1–10  M Cd. A  signiﬁcant  increase  in
the  expression  of genes  coding  for B[a]P  metabolizing  enzymes  (CYP1A1,  CYP1B1)  occurred
in a dose  and time  dependent  manner  at 3, 6, and  24  h  post  exposure.  Likewise,  a signiﬁ-
cant  increase  in  the  heavy  metal  responsive  gene  MT2A  was  observed  following  exposure
to  Cd.  The  EROD  activity  assay  conﬁrmed  signiﬁcant  increases  in CYP1(A/B)  activity  after
24 h of  exposure  to B[a]P  which  was  not  affected  by the  presence  of Cd. Co-exposure  to  low
concentrations  of Cd  and  B[a]P  were  consistent  with  changes  in  gene  expression  as  seen
with  single-compound  exposures.  These  experiments  are  the  ﬁrst  to provide  information
regarding  toxicological  responses  in the  RPTEC/TERT1  cell line that model  those  of the tar-
get tissue.  We  conclude  that these  cells  can provide  a  useful  tool  for future  toxicological
studies.
©  2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
Y-NC-Nthe CC  B
. Introduction
According to the National Cancer Institute and the
ational Institute of Diabetes and Digestive and Kidney
iseases, the incidences of renal cell carcinoma (RCC),
hronic kidney disease, and end-stage renal failure are
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signiﬁcantly and steadily increasing [34,18]. Approxi-
mately 10% of the U.S. adult population suffers from renal
diseases. Collectively, these diseases are etiologically
complex with environmentally mediated risk factors
contributing to an estimated 90% of cases. To address this
gap  in our understanding, the Tox21 initiative has set forth
goals  to develop improved in vitro models with which to
investigate human conditions, such as renal disease, that
may  be promoted by toxicant exposure [33].
In accordance with the Tox21 initiative, we  have pro-
posed to characterize immortalized renal cells that are
toxicological targets of environmental chemicals in the
 access article under the CC BY-NC-ND license (http://creativecommons.
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human kidney. Speciﬁcally, the renal proximal tubule
epithelial cells (RPTEC) in the kidney are a principal tar-
get  site of chemical and elemental toxicity [3,22]. We  have
examined metabolic responses to two model environmen-
tal toxicants in a novel, genetically modiﬁed human renal
cell  line, RPTEC/TERT1, derived from a normal, healthy
renal proximal tubule donor [36]. The RPTEC/TERT1 cell
line  has been immortalized using the catalytic subunit
of  human telomerase reverse transcriptase (hTERT), the
endogenous enzyme responsible for telomere stabilization.
Wieser et al. [36] have conﬁrmed the functional similar-
ity  of the RPTEC/TERT1 cell line to that of proximal tubule
cells  in the body by demonstrating that they exhibit a
normal, stable male diploid karyotype and prototypical
RPTEC structural and biochemical properties through more
than  90 population doublings [36]. While primary RPTECs
derived from normal, healthy, human tissue are the best
models  under certain, speciﬁc experimental protocols,
primary cells undergo replicative senescence in culture.
These properties make them difﬁcult if not impossible for
many  experimental protocols including chronic exposure
or  long-term studies. The RPTEC/TERT1 cell line does not
undergo  replicative senescence overcoming these limita-
tions  of primary RPTECs. Furthermore, primary RPTECs are
often  isolated from diseased patients, which may  inﬂu-
ence  their ability to model the normal, healthy tissue. The
near-normal properties of this cell line suggest that it may
provide  a promising new model with which to study the
toxicant-induced mechanisms of renal disease and cancer.
In  this study, we investigated transcriptional and
metabolic responses to benzo[a]pyrene (B[a]P), a rep-
resentative polycyclic aromatic hydrocarbon (PAH), and
cadmium  (Cd), a toxic heavy metal, in the RPTEC/TERT1
cell line. B[a]P, generated by the incomplete combus-
tion of organic material, is an environmental carcinogen
that may  play a role in renal cell carcinogenesis. Stud-
ies  suggest that increased B[a]P exposure through diet,
environment, and/or cigarette smoking can more than
double one’s risk for developing RCC [8,10,11]. B[a]P
is  rapidly bioactivated in the body to reactive epoxide
intermediates in the liver and other organs including
the proximal tubule of the kidney. Bioactivation occurs
primarily through cytochrome P450 enzymes, CYP1A1/2
and CYP1B1, and microsomal epoxide hydrolase (EPHX1)
[22,31,37]. These toxic metabolites readily react with cel-
lular  macromolecules. Glutathione conjugation leads to
metabolite detoxiﬁcation. However, B[a]P metabolites also
bind  DNA directly, forming bulky adducts [23,32]. If these
lesions  not repaired properly, mutations may  develop.
Cd  is a well-known nephrotoxicant and suspected renal
cell  carcinogen [20,29,35]. Cd is transported to the kidney
bound to small proteins such as metallothioneins. Nephro-
toxicity occurs when the Cd-metallothionein complex is
reabsorbed  in the proximal tubule where the metallothi-
onein is degraded freeing Cd [4,29]. Cd is not metabolized,
has a long biological half-life, and bioaccumulates primar-
ily  in the liver and kidneys [13,21]. Chronic effects of Cd
exposure may  be evident in Cd’s ability to promote cellular
oxidative stress as well as inhibit DNA repair, thus increas-
ing  the mutagenicity of genotoxicants [1,9,15]. Both B[a]P
and  Cd are found in the diet, environment, and tobaccoorts 1 (2014) 231–242
smoke, with each considered as contributing risk factors
to  the development of RCC [8,17,24].
To explore the potential mechanisms by which
these toxicants promote carcinogenesis, we treated
RPTEC/TERT1 cells with deﬁned concentrations of B[a]P
and  Cd separately and in combination. We  measured spe-
ciﬁc  toxicological responses and changes in the expression
of  genes encoding key biotransformation enzymes and
metal  binding proteins as well as selected functional differ-
ences  in biotransformation activity. We  hypothesize that
RPTEC/TERT1 cells which exhibit structural, biochemical,
and functional properties comparable to normal, healthy
RPTECs will respond to these xenobiotics and provide an
improved  model for future studies.
2. Materials and methods
2.1.  Cell culture
RPTEC/TERT1 cells and culture medium were purchased
from Evercyte Laboratories (Vienna, Austria) and cultured
according to the vendor’s instructions. RPTEC/TERT1 cells
were  passaged approximately once or twice per week and
subcultured at a 1:2 or 1:3 ratio. Human Kidney 2 (HK-
2)  cells, used for comparative purposes, were purchased
from ATCC (Manassas, VA) and cultured according to the
vendor’s  instructions. All cells were cultured at 37 ◦C in a
humidiﬁed atmosphere containing 5% CO2.
2.2. Chemicals
All  chemicals and enzymes were purchased from
Sigma–Aldrich, USA unless noted otherwise. Cadmium
chloride (CdCl2, 202908) was dissolved in fresh com-
plete medium and delivered at 0.1% of the ﬁnal
culture volume to yield the appropriate target concen-
trations. Benzo[a]pyrene (B[a]P, B1760) was dissolved
in  dimethyl sulfoxide (DMSO, D8418) and delivered at
0.05%  of the ﬁnal culture volume to yield the appro-
priate target concentrations. B[a]P preparations and
exposures were carried out and conducted under low light
conditions.
2.3.  Cytotoxicity
Cells were seeded at 10,000 cells per well and
exposed in 96-well microplate format to either Cd or
B[a]P  for the duration of the experimental time point.
Methylthiazolyldiphenyl-tetrazolium bromide (MTT,
Sigma, M5655) was used to assess cell viability. MTT  was
reconstituted to 5 mg/mL  in phenol red free basal medium
and  delivered at 10% volume directly to microplates. Cells
were  incubated at 37 ◦C in a humidiﬁed atmosphere of 5%
CO2 with MTT  for 3 h to allow the formation of formazan
crystals. After incubation, cells were lysed with an equalHCl,  isopropanol) and absorbance read at 570/690 nm.
Viabilities are expressed as percent of untreated control
for  Cd-exposed cells and percent of DMSO vehicle control
for  B[a]P-exposed cells.
B.R. Simon et al. / Toxicology Rep
Table 1
Primer-probe sets used for normalized, relative quantitative PCR for the
genes  under study. Pre-designed TaqMan® gene expression assays from
Applied Biosystems® were used to quantify gene expression. To mini-
mize the inﬂuence of residual genomic DNA contamination, genomic DNA
elimination using the QIAGEN method during RNA isolation. Additionally,
where possible, primer-probe sets spanning multiple exons were used to
further  reduce potential for genomic DNA interference.
Gene ID Gene function Gene location Assay ID
CYP1A1
Phase  I metabolism
15q24.1 Hs00153120 m1
CYP1B1 2p22.2 Hs00164383 m1
EPHX1 1q42.12 Hs01116806 m1
GSTT1
Phase  II metabolism
22q11.23 Hs00184475 m1
GSTM1 1p13.3 Hs02341469 m1
XPA DNA damage repair 9q22.33 Hs00166045 m1
MT1A 16q12.2 Hs00831826 s1
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MT2A 16q12.2 Hs02379661 g1
ACTB Reference 7p22.1 Hs99999903 m1
.4. Gene expression
RPTEC/TERT1 cells were grown to conﬂuence in 60 mm
ishes  and exposed to Cd or B[a]P as described above. Cells
ere  exposed in biological triplicates for each concentra-
ion and time point examined. Total RNA was isolated from
ells  after appropriate time points using the QIAshred-
er (QIAGEN, 79656) and RNeasy extraction kit (QIAGEN,
4136) following the manufacturer’s instruction. RNA
oncentration and purity was assessed using a Thermo Sci-
ntiﬁc  Nanodrop 2000c spectrophotometer. RNA samples
ere  diluted to 0.5 g/L in nuclease-free water.
Two  microliters of each RNA sample were used for cDNA
ynthesis reactions to deliver 1 g template in a 20 L total
eaction volume. cDNA was synthesized using iScript cDNA
ynthesis  (BioRad, 170-8891) protocol as follows: 5 min  at
5 ◦C, 30 min  at 42 ◦C, and 5 min  at 85 ◦C. RNA templates
nd cDNA were stored at −20 ◦C until use. Gene expres-
ion was determined using primer-probe sets from Applied
iosystems® TaqMan® Gene Expression Assays. Actin, beta
ACTB)  was used as a reference gene. A complete list of
rimers  used are listed in Table 1. The thermal cycling pro-
ocol  followed the manufacturer’s instructions: 50 ◦C for
 min  and 95 ◦C for 10 min  followed by 40 cycles of 95 ◦C
or  15 s and 60 ◦C for 1 min. Reactions were conducted in
0  L volumes with each sample being run in duplicate. All
eactions  were carried out using a BioRad C1000TM thermal
ycler equipped with a CFX96TM Real-Time PCR Detection
ystem.
.5. Genotyping
Genomic DNA was isolated from healthy, untreated
PTEC/TERT1 cells using a standard phenol:chloroform
NA extraction procedure. Brieﬂy, cell pellets were incu-
ated  with Tris-EDTA (TE) buffer, RNaseT1, mRNAse A, and
odium  dodecyl sulfate (SDS) for 45 min  at 37 ◦C. Next, pel-
ets  were then incubated with proteinase K for 60 min  at
0 ◦C and then overnight at 37 ◦C. Deproteinized DNA was
xtracted using the 5 PRIME Phase Lock Gel light method
n  15 ml  tubes (Fisher-Scientiﬁc, Pittsburg, PA), to increase
he  yield from the aqueous phase. Precipitated DNA was
pooled onto a glass pipette, transferred to 70% ethanol,orts 1 (2014) 231–242 233
and  collected by centrifugation (14,000 rpm for 10 min).
Ethanol was  decanted and DNA was  allowed to dry com-
pletely before reconstituting in sterile, DNA-grade water.
DNA  concentration and purity was assessed using a Thermo
Scientiﬁc Nanodrop 2000c spectrophotometer.
RPTEC/TERT1 genomic DNA was provided to the Coriell
Institute for Medical Research (Camden, NJ) and geno-
typed using the Affymetrix GeneChipTM Genome-Wide
Human SNP Array 6.0 and the Affymetrix DMETTM Drug
Metabolism Array. See supplemental material for genotyp-
ing  results.
2.6. CYP1(A/B) enzymatic activity
To assess enzymatic activity and functional response to
exposure, RPTEC/TERT1 cells were treated at conﬂuence in
12-well  tissue culture treated plates. After exposure time
points,  cells were washed twice with cold 1X phosphate
buffered saline (PBS) and stored in sealed 12 well plates at
−80 ◦C for a minimum of 24 h before ethoxyresoruﬁn-O-
deethylase (EROD) activity assay was determined.
Previously exposed and frozen cells, in 12-well plate
formats, were removed from −80 ◦C storage and thawed
rapidly in a water bath at 37 ◦C then placed directly on
ice  for approximately 2 min. This freeze/thaw cycle was
repeated twice to ensure permeability of cell membranes.
A stock solution of EROD reaction mix  was  prepared in
50  mM Tris to deliver 100 L volumes to each well with
the  following concentrations: 5 M 7-ethoxyresoruﬁn,
0.5 mM NADPH, and 1 mg/mL bovine serum albumin (Jack-
son  ImmunoResearch Laboratories, Inc., West Grove, PA).
Cells  were incubated at 37 ◦C in a standard cell cul-
ture incubator for 1 h with EROD reaction mix. An eight
point standard curve was  made by diluting resoruﬁn from
0.098  ng resoruﬁn at 1:2 dilutions in 15% methanol: 85%
60  mM Tris (pH 7.1–7.4).
After incubation, 90 L EROD reaction mix  was removed
from each replicate of the 12-well plate (n = 3 per treatment
group) and added to an optically clear, 96-well microplate
to  which 70 L 2 M glycine had been added to stop the reac-
tion.  Standards were prepared in the same way  with 90 L
standard  and 70 L 2 M glycine (n = 3 for each dilution
point). Fluorescence was read immediately using a Tecan
Inﬁnite® 200 PRO multimode microplate reader, Tecan (San
Jose,  CA), at 535 excitation/570 emission. Resoruﬁn was
calculated for samples based on the standard curve. Val-
ues  were calculated as pg resoruﬁn/mg protein for each
sample and expressed as percent of respective control (or
vehicle)  treated group. Points represent mean percent pg
resoruﬁn/mg protein ± SEM.
2.7.  Metallothionein protein expression
Metallothionein (MTI/II) protein expression was  deter-
mined by immunoblotting using a modiﬁed Western
method [7]. Cells were plated in 100 mm dishes at 100,000
cells  per ml,  in a 10 ml  total volume and exposed to Cd
for  deﬁned time points. Protein was isolated and quan-
tiﬁed using the Bradford assay [5]. 50 g of protein was
loaded on AnykD gels (Bio-Rad), transferred to PVDF mem-
branes,  and probed with primary antibodies overnight.
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Fig. 1. Concentration- and time-dependent effects of Cd on the viability of
RPTEC/TERT1 cells after (A) 24 h, (B) 48 h and (C) 1 week of Cd exposure.
Viabilities are expressed as percent of untreated control, 0 M, at each
time point as indicated by the MTT  viability assay. Bars represent mean
viability (n = 8) ± SEM, * indicates signiﬁcant difference from 0 M at each234 B.R. Simon et al. / Toxico
The following primary antibodies were used from Abcam®
(Cambridge, MA): MTI/II, mouse monoclonal, ab12228,
and Actin, mouse monoclonal, ab8224. Excess primary
antibody was removed the next day and the secondary anti-
body,  goat anti-mouse (IR 680, LI-COR, Lincoln, NE) were
applied  for 1 h. Membranes were washed and visualized
using a LI-COR Odyssey Imaging System. Band density was
quantiﬁed  using ImageJ software, normalized to actin, and
expressed  as percent of untreated control for each time
point  [27].
2.8.  Statistical analysis
One-way  and two-way ANOVAs were performed using
the  GraphPad Prism analytical software, version 6.0 (San
Diego,  California). Data for the MTT  viability assays were
analyzed using a one-way ANOVA and Dunnett’s multiple
comparison test. Data for gene expression was analyzed
using a two-way ANOVA and Tukey’s post hoc test. An alpha
of  0.05 was used as the criteria for determining signiﬁcance.
General linear models were used to test for differences
among treatments, treatment groups, and timepoints for
the  EROD activity assay endpoints investigated. Where the
initial  GLM analysis of variance (GLM-ANOVA) indicated
a  signiﬁcant difference, post hoc mean comparisons were
conducted using a Dunnett’s correction. Statistical testing
was  conducted using IBM SPSS Statistics version 19 soft-
ware  (Armonk, New York). An alpha of 0.05 was used as
the  criteria for determining signiﬁcance.
3. Results
3.1. RPTEC/TERT1 cells demonstrate sensitivity to low
concentrations of Cd and B[a]P
In order to determine if RPTEC/TERT1 cells were sen-
sitive to the two renal toxicants, Cd and B[a]P, cells were
exposed to each in a 96-well microplate format. After 24 h,
48  h, or 1-week of exposure, cytotoxicity was  assessed
using the MTT  viability assay for each toxicant. Viability
assessments were used to determine both RPTEC/TERT1
sensitivity and appropriate, sub-toxic concentrations for
future  experiments.
3.2.  Cd induced cytotoxicity in RPTEC/TERT1 cells
After a 24-h exposure to Cd, RPTEC/TERT1 cells demon-
strated signiﬁcantly decreased viabilities at 15 and 30 M
Cd  with viabilities at 74.2 and 49.0% of untreated controls,
respectively (Fig. 1A). After a 48-h Cd exposure, all concen-
trations, with the exception of 1 M Cd, were signiﬁcantly
cytotoxic when compared to untreated cells (Fig. 1B). How-
ever,  after 1 week, cells showed recovery, or stabilization
in viability as in the case of 3 M Cd, from the previously
assessed time point for all concentrations except for groups
treated  with either 15 M or 30 M Cd. At the highest con-
centration, 30 M Cd, cell viability continued to decline
with a ﬁnal viability of less than 5% of the untreated controls
(Fig.  1C).respective time point, p < 0.001, and # indicates signiﬁcant difference from
0  M at each respective time point, p < 0.05.3.3. B[a]P induced cytotoxicity in RPTEC/TERT1 cells
B[a]P signiﬁcantly reduced cell viability after a 24-
h  exposure at concentrations as low as 0.001 M with
logy Reports 1 (2014) 231–242 235
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Fig. 2. Concentration- and time-dependent effects of B[a]P on the viabil-
ity of RPTEC/TERT1 cells after (A) 24 h, (B) 48 h and (C) 1 week of B[a]P
exposure. Viabilities are expressed as percent of vehicle control, DMSO,
at each time point as indicated by the MTT  viability assay. Bars represent
mean viability (n = 8) ± SEM, * indicates signiﬁcant difference from DMSO,B.R. Simon et al. / Toxico
iability at 84.1% of the DMSO-treated control cells,
 < 0.001 (Fig. 2A). Because viabilities were signiﬁcantly
ffected over a wide range of concentrations, 0.001 M
o  10 M B[a]P, cells were exposed to 1 × 10−21M B[a]P
o explore a non-cytotoxic concentration. Treatment with
 × 10−21M B[a]P did not signiﬁcantly reduce cell viabil-
ties at any time point (Fig. 2A–C). After a 48-h exposure
o B[a]P, RPTEC/TERT1 cell viabilities continued to decline
ith  viabilities below 62%, p < 0.01 (Fig. 2B). Although cells
ppeared to recover after the 48-h exposure time point,
iabilities remained signiﬁcantly reduced after 1 week fol-
owing  the initiation of B[a]P exposure (Fig. 2C).
.4. Cd and B[a]P stimulate compound-speciﬁc changes
n  gene expression in RPTEC/TERT1 cells
Next we selected key genes to characterize changes in
PTEC/TERT1 cells in response to speciﬁc concentrations of
[a]P  or Cd at 3, 6, and 24 h post-exposure. Refer to Table 1
or  gene ID listing and assay information. Although GSTM1
nd  GSTT1 expression was  examined at all concentrations
nd time points, neither genes were detected by RT-PCR
data not shown). Our analysis of XPA at all concentrations
nd time points showed constitutively expressed levels of
he  gene that were not signiﬁcantly altered by any treat-
ent  or time point (data not shown).
We examined Phase I metabolic enzyme gene expres-
ion in the RPTEC/TERT1 cell line after exposure to B[a]P
r  Cd. RPTEC/TERT1 cells showed concentration- and time-
ependent changes in CYP1A1 (Fig. 3A) and CYP1B1 (Fig. 3C)
ene  expression after exposure to B[a]P but not Cd (Fig. 3F
nd  G). Expression of CYP1A1 was not detected in the
bsence of B[a]P treatment. However, CYP1A1 gene expres-
ion  was most signiﬁcantly upregulated after 3 h of B[a]P
xposure with levels declining toward baseline after 24 h
Fig.  3A). CYP1B1 gene expression was constitutive in
PTEC/TERT1 cells with induction increasing most sig-
iﬁcantly after 24 h of exposure to 1 M B[a]P (Fig. 3C).
imilar to CYP1A1 gene expression, all concentrations of
[a]P  examined induced a CYP1B1 expression response.
ene expression of EPHX1 was constitutive in RPTEC/TERT1
ells, but no signiﬁcant changes in gene expression were
bserved after any treatment or time point (Fig. 3E and H).
K-2  cells, a virally transformed human proximal tubule
pithelial cell line, were used for comparative purposes.
K-2 cells exhibited constitutive, low level expression of
YP1A1  and CYP1B1; however, there was no signiﬁcant con-
entration  or time dependent change in CYP1A1 or CYP1B1
t  3, 6, or 24 h after B[a]P exposure (Fig. 3B and D).
Gene  expression of the canonical heavy metal binding
roteins, metallothionein (MT1A and MT2A), was  deter-
ined after exposure to B[a]P or Cd. Signiﬁcant differences
n  MT1A and MT2A were detected after Cd exposure (Fig. 4A
nd  B) but not after B[a]P exposure (Fig. 4C and D).
.5.  Co-exposure to Cd and B[a]P does not alter gene
xpression responses to single compounds
Because the kidney is exposed to mixtures of toxicants
hile ﬁltering and reabsorbing nutrients in the body, we
p  < 0.001, † indicates signiﬁcant difference from DMSO, p < 0.01, # indicates
signiﬁcant difference from DMSO, p < 0.05.
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Fig. 3. Compound-speciﬁc as well as concentration- and time-dependent changes in gene expression are observed in phase I metabolic enzymes in
RPTEC/TERT1  cells but not HK-2 cells. RPTEC/TERT1 cells were treated with B[a]P or Cd for 3, 6, and 24 h. HK-2 cells were exposed to B[a]P for 3, 6, and 24 h
for  comparative purposes. (A) CYP1A1 and (C) CYP1B1 gene expression increased signiﬁcantly after exposure to B[a]P in RPTEC/TERT1 cells at all time points
while  HK-2 cells showed no response to B[a]P after any time point (B) and (D). There were no signiﬁcant changes in (E) EPHX1 gene expression detected
after  B[a]P treatment. Additionally, no signiﬁcant changes in gene expression were detected in (F) CYP1A1, (G) CYP1B1, or (H) EPHX1 after Cd treatment
at  any time point or concentration. Bars represent mean fold expression (n = 3) ± SEM. All genes of interest were normalized to ACTB. Expression of genes
in  the DMSO or 0 M control groups, where denoted, was set to 1. * Indicates signiﬁcant difference from DMSO or 0 M controls at each respective time
point,  p < 0.001, † indicates signiﬁcant difference from DMSO or 0 M controls at each time point, p < 0.01, # indicates signiﬁcant difference from DMSO
or  0 M controls at each time point, p < 0.05, [*] indicates signiﬁcant difference from 1 M B[a]P at 3 h, p < 0.001, /*/ indicates signiﬁcant difference from
1  M B[a]P at 24 h, p < 0.001, (#) indicates signiﬁcant difference from 0.1 M B[a]P at 3 h, p < 0.05, <#> indicates signiﬁcant difference from 1 M B[a]P at
3  h, p < 0.05, and {#} indicates signiﬁcant difference from 1 M B[a]P at 24 h, p < 0.05.
B.R. Simon et al. / Toxicology Reports 1 (2014) 231–242 237
Fig. 4. Treatment with Cd but not B[a]P resulted in signiﬁcant changes in MT1A and MT2A gene expression in RPTEC/TERT1 cells. Exposure to Cd resulted in
a  signiﬁcant increase in (A) MT1A at 10 M Cd after 6 h and in (B) MT2A after 3, 6, and 24 h. In contrast, exposure to B[a]P after 3, 6, and 24 h did not result in
signiﬁcant  changes in (C) MT1A or (D) MT2A gene expression. Bars represent mean fold-expression (n = 3) ± SEM. All genes of interest were normalized to
ACTB.  Expression of genes in the DMSO or 0 M control groups, where denoted, was  set to 1. * Indicates signiﬁcant difference from DMSO or 0 M controls
at  each respective time point, p < 0.001, † indicates signiﬁcant difference from DMSO or 0 M controls at each time point, p < 0.01, # indicates signiﬁcant
d cates signiﬁcant difference from 1 M Cd at 24 h, p < 0.001, /*/ indicates signiﬁcant
d ce from 10 M Cd at 6 h, p < 0.01, [†]  indicates signiﬁcant difference from 10 M
C  h, p < 0.05, and {#} indicates signiﬁcant difference from 10 M Cd at 6 h, p < 0.05.
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Fig. 5. Co-exposure to Cd and B[a]P resulted in a signiﬁcant increase
in cytotoxicity at the highest dose only. After 24 h of either 0 M Cd,
0.1 M Cd, or 1 M Cd, cells were exposed to concentrations of B[a]P forifference  from DMSO or 0 M controls at each time point, p < 0.05. [*] Indi
ifference  from 10 M Cd at 6 h, p < 0.001, (†)  indicates signiﬁcant differen
d  at 24 h, p < 0.01, (#) indicates signiﬁcant difference from 10 M Cd at 24
haracterized cytotoxicity and gene expression responses
f  the RPTEC/TERT1 cell line after co-exposure to Cd and
[a]P.  Cells were treated with 1 M Cd for 24 h followed
y exposure to concentrations of B[a]P for 24 h. Treatment
ith 1 M Cd alone did not signiﬁcantly alter cell viability
t  any time point post-exposure (Fig. 1A–C). Cytotoxic-
ty under co-exposure conditions was determined using
he  MTT  assay. Only cells treated with 1 M Cd for 24 h
nd  10 M B[a]P for 24 h were signiﬁcantly different from
ntreated controls, p < 0.001 (Fig. 5).
Patterns  of gene expression after co-exposure fol-
owed those seen after single compound exposures. Phase
 metabolic enzymes CYP1A1 and CYP1B1 showed an
nduction in gene expression, most signiﬁcantly at 1 M
d  × 1 M B[a]P (Fig. 6A and B). There was no signif-
cant increase in EPHX1 gene expression after single
ompound exposures. However EPHX1 expression was
odestly, but signiﬁcantly increased after co-exposure to M Cd × 1 M B[a]P (Fig. 6C). There was no change in
T1A gene expression (Fig. 6D) whereas MT2A was  sig-
iﬁcantly increased after treatment with 1 M Cd × 1 M
[a]P  (Fig. 6E).
24 h. Only groups exposed to 1 M Cd × 10 M B[a]P signiﬁcantly differed
from untreated controls, p < 0.001. Viabilities are expressed as percent
DMSO control as determined by the MTT  viability assay. Points represent
mean ± SEM (n = 8).
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Fig. 8. Change in metallothionein protein was detected after exposure to
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.6. Enzymatic activity increases in CYP1(A/B) with B[a]P
xposure
The  EROD activity assay was performed at 3, 6, and 24 h
ost-exposure to B[a]P and after Cd x B[a]P co-exposure
onditions to conﬁrm CYP1(A/B) enzymatic activity and
unction  (Fig. 7). Signiﬁcant increases in CYP1(A/B) enzy-
atic  activity were detected after 24 h of exposure to
.1  M and 1 M B[a]P alone. Additionally, there were sig-
iﬁcant increases in enzymatic activity after co-exposure to
 M Cd × 0.01 M B[a]P and 1 M Cd × 1 M B[a]P. There
as no signiﬁcant effect due to Cd treatment under co-
xposure conditions.
.7.  Metallothionein protein expression
MTI/IIA protein levels were determined by
mmunoblotting after 48 h and after 1 week of expo-
ure to 1 M and 10 M Cd (Fig. 8). After 48 h of exposure,
PTEC/TERT1 cells show the greatest increase in MTI/IIA
rotein at 1 M Cd. Densitometry of bands revealed over a
90%  increase in MTI/IIA protein after exposure to 1 M Cd
or  48 h and over a 140% increase after exposure to 10 M
d  for 48 h in comparison to untreated controls. After
 week of exposure, MTI/IIA protein remained elevated
n  cells exposed to 1 M Cd and 10 M Cd with levels
xceeding 150% and 160%, respectively, when compared
o  untreated controls.
.  Discussion
At  present, the majority of human in vitro, immortal-
zed models rely on cells that retain an ability to proliferate
ue to a tumorigenic phenotype or through viral transfor-
ation. Although these cell lines have provided tools for
xperimentation, their altered states may  not adequatelyProtein bands were quantiﬁed using ImageJ software, normalized to Actin,
and  expressed as percent of untreated control.
model normal, healthy human cells in the tissue of inter-
est.  Unstable or tumor-derived in vitro models make it
difﬁcult  to study the progression of healthy cells to tumori-
genic  ones. New evidence suggests that tumor derived
cell lines grown in culture are less likely to resemble
cells in the original tumor tissue. Recently, transcriptional
analyses of several cell lines derived from diverse tumor
tissues including glioblastoma, colorectal cancer, breast
cancer, metastatic melanoma, leukemia, and ovarian can-
cer  have revealed a greater similarity of the cell lines to
each  other than to their respective tumor tissues [16].
Because many of these cell lines are less sensitive than
their normal biological counterparts to chemically induced
effects,  substantially higher concentrations of compounds
are  required to produce a signiﬁcant response. Therefore,
some of these immortalized cell lines may  not be suitable
models to accurately represent xenobiotic biotransforma-
tion or DNA repair capacity, as it would occur in vivo. In
order  to provide the most relevant information for trans-
lating  in vitro toxicity tests using immortalized cell lines
to  human health and risk assessment, it is imperative to
conduct  experiments under biologically appropriate con-
ditions  [19].
Renal  proximal tubule epithelial cells are primarily
responsible for reabsorption of nutrients in the kidney.
These cells are uniquely susceptible to toxicants and dam-
age  as they are the ﬁrst cells exposed to tubular ﬁltrate
[30]. Consequently, renal proximal tubule epithelial cells
are  continuously exposed to potentially damaging agents,
which  can contribute to and promote the progression of
renal  diseases and renal cell carcinogenesis [22]. With the
incidence  of kidney and renal pelvis diseases and cancers
signiﬁcantly increasing over the last several decades, it is
important  to develop suitable in vitro models which can be
logy Rep240 B.R. Simon et al. / Toxico
utilized to examine mechanisms and causal factors of renal
malignancy [18].
Many  in vitro studies focused on human kidney function
and diseases have relied on the Human Kidney-2 cell line
(HK-2).  The HK-2 cell line, isolated in 1994 from human
renal proximal tubule cells, was immortalized with the
human  papilloma virus 16 (HPV16) E6 and E7 genes. While
studies  characterizing the HK-2 cell line have demon-
strated their ability to reproduce results seen in isolated
proximal tubule cells, the transformation with E6/E7 genes
is  now known to lead to aberrant cell growth, signaling, and
in  vitro properties that may  not correctly reﬂect normal
proximal tubule cells [26,28].
The goal of this initial, targeted toxicological evalua-
tion was to examine selected toxicant induced responses
in  a novel, immortalized RPTEC line that may  model
the target tissue better than other widely available cell
lines.  We  argue that primary RPTECs are likely better
in  vitro models for evaluating toxicological effects on renal
cells  but only under certain experimental protocols. Pri-
mary  RPTECs are often obtained from diseased patients,
they undergo replicative senescence in culture, and their
xenobiotic metabolizing properties may  change in cul-
ture,  as do primary hepatocytes. Where primary RPTECs
from healthy, human donors can be obtained and used
for  appropriate experimental protocols, they should be
the  preferred model. We  suggest that our work herein
was conducted to provide a rationale for using this novel,
immortalized RPTEC/TERT1 cell line in toxicological stud-
ies  where those criteria cannot be met. Our experiments
in the RPTEC/TERT1 cell line demonstrate their chemical
sensitivity and metabolic capacity when exposed to low
concentrations of single and binary combinations of B[a]P
and  Cd. In the RPTEC/TERT1 cell line, sensitivity to single
compounds was exhibited at concentrations as low as 1 nM
B[a]P  and 3 M Cd. Unlike Cd, B[a]P must be bioactivated in
order  to cause cytotoxicity and mutagenicity [2]. Increased
cytotoxicity in RPTEC/TERT1 cells due B[a]P exposure sug-
gests  bioactivation of the parent compound, B[a]P, to its
toxic  metabolites.
While there are very limited studies examining the
effects of B[a]P on human kidney cells, strong evidence sup-
ports  the link between PAH consumption and an increase
in  RCC risk [10,11]. Signiﬁcant increases in CYP1A1 and
CYP1B1 gene expression were detected in RPTEC/TERT1
cells after B[a]P exposure but not after Cd-only exposure.
This demonstrates dynamic dose responsiveness at the
gene  expression level. HK-2 cells, used here as a com-
parative model, showed no signiﬁcant differences in gene
expression due to B[a]P exposure at any concentration or
time  point. In HK-2 cells, CYP1A1 was detected at late cycle
times,  between 31 and 34 out of 40 PCR cycles, and CYP1B1
was  detected between 25 and 26 out of 40 PCR cycles.
Because HK-2 cells were immortalized by transformation
with HPV-16 E6/E7, it is possible that these properties may
be  promoting constitutive, ectopic, dysfunctional expres-
sion  of CYP1A1, CYP1B1, and other genes not included in our
studies.  Additionally, RPTEC/TERT1 cells exhibited appro-
priate  compound-speciﬁc responses such that cells treated
with  Cd alone did not mirror responses seen when cells
were  treated with B[a]P alone. Likewise, cells treated withorts 1 (2014) 231–242
Cd  responded with signiﬁcant increases in MTI/II as would
be  expected following heavy metal exposure.
Cd is known to have a long biological half life of several
decades, up to 30 years, and accumulates in the proximal
tubules of the kidney [12]. We exposed RPTEC/TERT1 cells
to  1 M Cd for 24 h followed by concentrations of B[a]P
for 24 h in order to determine effects of co-exposure to
B[a]P  and Cd as would occur in the environment. Under
co-exposure, cells showed responses similar to those after
exposure  to each single compound with an increase in
CYP1A1,  CYP1B1, and MT2A. A small but signiﬁcant increase
in  EPHX1 after co-exposure, which was  not detected after
single  compound exposure, suggests increased oxidative
stress due to the presence of both compounds. We  aim
to  investigate this effect in terms of mixtures, oxidative
stress, and mutagenesis with ongoing studies using the
RPTEC/TERT1 cell line.
Signiﬁcant  increases in enzymatic activity were
detected with the EROD activity assay after 24 h of B[a]P
exposure and under co-exposure conditions. Because
the EROD assay speciﬁcally detects CYP1A activity, the
increase in EROD seen in the RPTEC/TERT1 cell line after
B[a]P  exposure suggests activation of the AhR signaling
pathway [2,6]. We hypothesize that the AhR pathway
would be activated in this cell line after exposure to
biologically relevant concentrations of many AhR ligands.
This  data further conﬁrms functional and appropriate
metabolic responses to environmental toxicants in the
RPTEC/TERT1 cell line.
Many  experiments studying PAHs such as B[a]P have
been carried out in human liver cells derived from hepa-
tocellular carcinoma (HepG2) as well as human bronchial
epithelial cells derived from a carcinoma (A549). However,
the  tumorigenic nature of these cell lines calls into ques-
tion  their accurate representation of prototypical biological
responses. Using these cells to model normal, healthy cells
and  organs in toxicological experiments is far from ideal.
The  kidneys have been known to activate, metabo-
lize, and detoxify xenobiotics through all of the typical
Phase I and Phase II metabolic reactions. Since the 1960s,
renal  CYP activity has been studied as a key component of
drug  biotransformation and toxicity in the kidney. Xenobi-
otics  such as analgesics, barbiturates, chemotherapeutics,
alcohol, and immunosuppressive agents have been widely
studied  and shown to induce the renal CYP system to vary-
ing  degrees. Early in vivo experiments using B[a]P have
veriﬁed the presence and activation of CYPs in the kidney
[25].  Likewise, studies detailing Cd’s transport, bioaccumu-
lation, promotion of oxidative stress, and inhibition of DNA
repair  pathways in renal proximal tubule cells have vali-
dated  the heavy metal as a suspected renal cell carcinogen
[20,21,35].
Our results demonstrate the canonical properties of
active renal metabolism in a human cell line derived from
normal,  healthy kidney tissue. Additionally, these cells
respond to environmental toxicants at levels lower than
those  shown in other metabolically competent cell lines
[14,25,32]. Because actual human exposures in the envi-
ronment are to mixtures of chemicals and compounds,
we are primarily interested in expanding scientiﬁc knowl-
edge  of how these mixtures may  promote chemically
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nduced responses and potentiate carcinogenesis. Our
esults  demonstrate that the RPTEC/TERT1 cell line can
e  used to study a binary mixture of two carcinogens
ith distinctly different modes of action. Future research
xamining the toxicological effects of this binary mix-
ure  in addition to more complex mixtures should be
onsidered as a model of biologically relevant exposure
cenarios. Ongoing studies are necessary to further verify
he  metabolic properties of RPTEC/TERT1 cells. Quantify-
ng  and tracking known biomarkers of exposure to B[a]P,
uch  as BPDE-DNA adducts, as well as effects seen in the
resence of Cd, will provide essential mechanistic infor-
ation regarding the ability of the RPTEC/TERT1 cell line
o  accurately model the kidney [37]. By characterizing
he RPTEC/TERT1 cell line for exposure and toxicological
esearch, we aim to provide a model toxicological system
hich  better represents responses that may  occur in nor-
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